Sarkozy to launch rare disease initiative
This article was originally published in Scrip
Nicolas Sarkozy, France's president, says he will develop a second national plan for rare diseases next year and put it in place by 2010 at the latest. He has also agreed that the funding established previously for national rare disease reference centres – there are around 100 hospital-based co-ordinating centres in France, each specialised in a rare disease – would be made permanent (Scrip Online, February 8th, 2006). Mr Sarkozy said rare diseases were a priority during France's current presidency of the European Union, estimating that 30 million Europeans suffer a rare disease. A communication on the subject from the European Commission is expected before the end of the year. The Alliance Maladies Rares, a French patient organisation, welcomed news of the plan, saying the first plan had not met all of its objectives.Leem, the French pharmaceutical industry association, hopes that research will be a key element in the second plan.
You may also be interested in...
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.